1. Sarepta Therapeutics Elects Biopharmaceutical Veteran, Michael W. Bonney, to its Board of Directors

    Sarepta Therapeutics Elects Biopharmaceutical Veteran, Michael W. Bonney, to its Board of Directors

    "Sarepta and its board of directors are greatly enhanced with the appointment to our board of Mike Bonney, one of the most respected biopharmaceutical leaders," said M. Kathleen Behrens, Ph.D., chair of Sarepta's board of directors . "Mike's list of accomplishments is long and his impact on this industry ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Sarepta and its board of directors are greatly enhanced with the appointment to our board of Mike Bonney, one of the most respected biopharmaceutical leaders.
    2. Sarepta stands at a moment of great inflection as we continue the successful launch of our first therapy for the treatment of Duchenne muscular dystrophy while accelerating with a sense of urgency our rich precision genetic medicine pipeline.
    3. Sarepta's mission and technology are critically important for children with DMD, their families and potentially a range of patients living with other diseases.
  3. Topics Mentioned